nach oben

Acta Neurochirurgica

Erschienen in:

01.03.2010 | Experimental Research

A new approach to the treatment of cerebral vasospasm: the angiographic effects of tadalafil on experimental vasospasm

verfasst von: Ender Koktekir, Yavuz Erdem, Mehmet Akif Bayar, Cevdet Gokcek, Mete Karatay, Celal Kilic

Erschienen in: Acta Neurochirurgica | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

The pathogenesis of cerebral vasospasm is likely to be multifactorial. Strong evidence has indicated that decreasing levels of NO after SAH seem to be important. A PDE-V inhibitor, tadalafil, theoretically increases NO levels. Our study investigated the vasodilatory efficacy of tadalafil on the cerebral arteries with measurement of basilar artery diameters on angiography.

Methods

We used 42 male Wistar-Albino rats to test our hypothesis. They were assigned randomly into the following seven groups: group 1: control (only saline), group 2: SAH only (killed on day 2), group 3: SAH + tadalafil (killed on day 2), group 4: SAH only (killed on day 4), group 5: SAH + tadalafil (killed on day 4), group 6: saline + tadalafil (killed on day 2) and group 7: saline + tadalafil (killed on day 4). The three different parts of basilar artery diameters were measured angiographically.

Results

There were statistically significant differences between the SAH and SAH groups treated with tadalafil at days 2 and 4. Comparison between control and tadalafil groups showed no significant differences. This result indicated that tadalafil has a vasodilatory effect on vasoconstricted arteries, but no effect on normal basilar arteries.

Conclusion

Our study results showed that tadalafil has a vasodilatory effect on both acute and chronic periods of cerebral vasospasm. We also concluded that cerebral angiography can be used safely for investigation of cerebral vasospasm in animal studies.

Afshar JK, Pluta RM, Boock RJ, Thompson BG, Oldfield EH (1995) Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 83(1):118–122CrossRefPubMed

Seftel AD (2005) Phosphodiesterase type 5 inhibitors: Molecular pharmacology and interactions with other phosphodiesterases. Current Pharmaceutical Design 11:4047–4058CrossRefPubMed

Armstead WM, Leffler CW (1992) Neurohumoral regulation of cerebral circulation. Exp Biol Med 199:149–157

Arnavaz A, Aurich A, Weissenborn K, Hartmann U, Emrich HM, Schneider U (2003) Effect of sildenafil (Viagra) on cerebral blood flow velocity: a pilot study. Psychiatry Res 122(3):207–209CrossRefPubMed

Atalay B, Caner H, Cekinmez M, Ozen O, Celasun B, Altinors N (2006) Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 59(5):1102–1107 discussion 1107-8PubMed

Blount MA, Beasley A, Zoraghi R, Sekhar KR, Bessay EP, Francis SH, Corbin JD (2004) Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation. Mol Pharmacol 66(1):144–152CrossRefPubMed

Cansever T, Canbolat A, Kırış T, Sencer A, Civelek E, Karasu A. Effects of arterial and venous wall homogenates, arterial and venous blood, and different combinations to the cerebral vasospasm in an experimental model. Surg Neurol. 2008 May 29. [Epub ahead of print]

Delgado T, Brismar J, Svendgaar NA (1985) Subarachnoid hemorrhage in the rat: angiography and fluorescence microscopy of the mjor cerebral arteries. Stroke 16:595–602PubMed

Dietrich HH, Dacey RG (2000) Molecular keys to the problems of cerebral vasospasm. Neurosurgery 46:517–530CrossRefPubMed

10.

Dorsch NWC, King MT (1994) A review of cerebral vasospasm in aneurysmal subarachnoid hemorrhage: I. Incidence and effect. J Clin Neuroscience 1:19–26CrossRef

11.

Edwards DH, Byrne JV, Griffith TM (1992) The effect of chronic subarachnoid hemorrhage on basal endothelium-derived relaxing factor activity in intrathecal cerebral arteries. J Neurosurg 76:830–837CrossRefPubMed

12.

Faraci FM, Brian JE (1994) Nitric oxide and the cerebral circulation. Stroke 25(3):692–703PubMed

13.

Fletcher TM, Taveras M, Pool JL (1959) Cerebral vasospasm in angiography for intracranial aneurysms. Incidence and significance in one hundred consecutive angiograms. Arch Neurol 1:38–47PubMed

14.

Inoha S, Inamura T, Ikezaki K, Nakamizo A, Amano T, Fukui M (2002) Type V phosphodiesterase expression in cerebral arteries with vasospasm after subarachnoid hemorrhage in a canine model. Neurol Res 24(6):607–612CrossRefPubMed

15.

Kim P, Schini VB, Sundt TM Jr, Vanhoutte PM (1992) Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Circ Res 70(2):248–256PubMed

16.

Longo M, Blandino A, Ascenti G, Ricciardi GK, Granata F, Vinci S (2002) Cerebral angiography in the rat with mammographic equipment: a simple, cost-effective method for assessing vasospasm in experimental subarachnoid haemorrhage. Neuroradiology 44(8):689–694 Epub 2002 Jul 20CrossRefPubMed

17.

Macdonald RL, Weir BKA (1991) A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22:971–982PubMed

18.

Mayberg M (1998) Cerebral vasospasm. Neurosurg Clin N Am 9:615–627PubMed

19.

Megyesi JF, Vollrath B, Cook DA, Findlay JM (2000) In vivo animal models of cerebral vasospasm: a review. Neurosurgery 46(2):448–460 discussion 460-1CrossRefPubMed

20.

Neumeyer K, Kirkpatrick P (2004) Tadalafil and vardenafil. Nat Rev Drug Discover 3(4):295–296CrossRef

21.

Nishizawa S, Yamamato S, Tokoyama T, Uemura K (1997) Dysfunction of NO induces protein kinase C activation resulting in vasospasm after SAH. Neurol Res 19:558–562PubMed

22.

Ohta S, Nishihara J, Oka Y, Todo H, Kumon Y, Sasaki S (1995) Possible mechanism to induce protein kinase C-dependent arterial smooth muscle contraction after subarachnoid hemorrhage. Acta Neurochir (Wien) 137:217–225CrossRef

23.

Osaka K (1977) Prolonged vasospasm produced by the breakdown products of erytrocytes. J Neurosurgery 47:403–411CrossRef

24.

Pluta RM, Oldfield EH, Boock RJ (1997) Reversal and prevention of cerebral vasospasm by intracarotid infusion of nitric oxide donors in a primate model of subarachnoid hemorrhage. J Neurosurgery 87:746–751CrossRef

25.

Prisant LM (2006) Phosphodiesterase-5 inhibitors and their hemodynamic effects. Curr Hypertens Rep 8(4):345–351 ReviewCrossRefPubMed

26.

Solomon RA, Antunes J, Chen RYZ et al (1985) Decrease in cerebral blood flow in rats after experimental subarachnoid hemorrhage: a new animal model. Stroke 16:58–66PubMed

27.

Yaşargil MG. Clinical considerations, surgery of the intracranial aneurysms and result In. Microneurosurgery Vol.II, Thieme Stratton Inc. New-York 1990; pp 17–18

28.

Youmans JR (1990) Neurological surgery. WB Saunders Co, Philedelphia, pp 1644–1660

29.

Weidauer S, Vatter H, Dettmann E, Seifert V, Zanella FE (2006) Assessment of vasospasm in experimental subarachnoid hemorrhage in rats by selective biplane digital subtraction angiography. Neuroradiology 48(3):176–181 Epub 2006 Feb 2CrossRefPubMed

30.

Weir B, Macdonald RL, Stoodley M (1999) Etiology of vasospasm. Acta Neurochir Suppl (Wien) 72:27–46

31.

Wilkins RH (1980) Attempted prevention or treatment of intracranial arterial spasm: a survey. Neurosurgery 6(2):198–210CrossRefPubMed

32.

Willette RN, Shiloh AO, Sauermelch CF, Sulpizio A, Michell MP, Cielinski LB, Torphy TJ, Ohlstein EH (1997) Identification, characterization and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors. J Cereb Blood Flow Metab 17(2):210–219CrossRefPubMed

33.

Woszczyk A, Deinsberger W, Bo¨ker D-K (2003) Nitric oxide metabolites in cisternal CSF correlate with cerebral vasospasm in patients with a subarachnoid haemorrhage. Acta Neurochir (Wien) 145(4):257–263 discussion 263-4CrossRef

34.

Zubkov AY, Nanda A, Zhang JH (2003) Signal transduction pathways in cerebral vasospasm. Pathophysiology 9:47–61CrossRefPubMed

Titel: A new approach to the treatment of cerebral vasospasm: the angiographic effects of tadalafil on experimental vasospasm
verfasst von: Ender Koktekir
Yavuz Erdem
Mehmet Akif Bayar
Cevdet Gokcek
Mete Karatay
Celal Kilic
Publikationsdatum: 01.03.2010
Verlag: Springer Vienna
Erschienen in: Acta Neurochirurgica / Ausgabe 3/2010
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI: https://doi.org/10.1007/s00701-009-0540-x

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2010

Factor XIII deficiency as a potential cause of supratentorial haemorrhage after posterior fossa surgery

Intracranial pressure pulse amplitude during changes in head elevation: a new parameter for determining optimum cerebral perfusion pressure?

Pediatric colloid cysts of the third ventricle: management considerations

Metastasis development at the site of cervical spine arthrodesis

Subdural effusion secondary to decompressive craniectomy in patients with severe traumatic brain injury